All GP articles
-
NICE guidelineNICE gout guideline
Covering diagnosis, management, and referral to specialist services
-
NICE guideline
NICE managing COVID-19 guideline
Summary of NICE guidance on the management of COVID-19 in children, young people, and adults in primary care settings
-
Supplement
WEBINAR REPORT: Best practice: Management of mental health in patients with acne
This report and the webinar have been commissioned and funded by L’Oréal (UK) Limited and developed in partnership with Guidelines and Guidelines in Practice.
June 2022 -
News
BMS, RCOG, and SfE publish joint position statement on menopause care
The statement focuses on considerations for hormone replacement therapy, with evidence and recommendations on the benefit/risk profile of different options
-
PHE/DH/DWP guideline
UKHSA monkeypox guidance
Providing information and advice for healthcare professionals on monkeypox. Includes vaccination recommendations and a useful contact tracing table
-
Guidance card
Liraglutide 6 mg/ml solution for injection in pre-filled pen (Saxenda®) SMC2455
Information intended for UK healthcare professionals only. The production of this Guidelines card has been commissioned by Novo Nordisk Limited.
View Saxenda® (liraglutide 3 mg) Great Britain and Northern Ireland prescribing information and adverse event reporting information.
UK22SX00249
Date of preparation: June 2022 -
News
Consensus statement on monkeypox published
As cases rise, the UK’s public health agencies have published a consensus statement about preventing and treating monkeypox
-
News
World No Tobacco Day 2022—poisoning our planet
Taking place on 31 May, the focus of World No Tobacco Day this year is on the environmental impact of the tobacco industry
-
Working party guideline/algorithm
Best practice treatment and management of patients with type 2 diabetes, cardiovascular disease, and heart failure
This management algorithm was developed by a multidisciplinary expert panel: Javaid et al with the support of an educational grant from AstraZeneca. Information intended for UK healthcare professionals.
-
News
New guidance published on eating-disorder-related medical emergencies
New RCP guidance covers the recognition and management of medical emergencies in eating disorders, as hospitalisations rise significantly
-
News
10-year plan to tackle dementia announced
A new 10-year plan to tackle dementia and boost neurodegenerative disease research will be published later in the year
-
News
Four more monkeypox cases in UK bring total to seven
The UK Health Security Agency (UKHSA) has announced a further four cases of monkeypox in the UK
-
News
Robotic surgery improves patient recovery times and is safer, finds new study
A recent clinical trial revealed faster recovery times for patients when bladder cancer removal and reconstruction was done with robot-assisted surgery
-
News
NICE recommends combination drug for women with uterine fibroids
Approximately 4500 women with uterine fibroids will be eligible to receive the drug
-
Hosted content
Anticoagulation management for elderly patients with NVAF, CKD and other comorbidities
This promotional webinar was organised and funded by the Bristol Myers Squibb/Pfizer Alliance and is intended for UK healthcare professionals only.
Click HERE to view ELIQUIS (apixaban) prescribing information and adverse events reporting
Adverse events should be reported. Reporting forms and information can be found at: UK – www.mhra.gov.uk/yellowcard, or search for MHRA Yellow Card in the Google Play or Apple App Store Adverse events should also be reported to Bristol-Myers Squibb via medical.information@bms.com or 0800 731 1736 (UK).
432-GB-2200204 May 2022 -
News
NHS staffing should pre-empt the changing medical needs of the UK
NHS staffing and training need to be more ‘fluid’ in response to the health needs of the nation, said a speaker at a meeting of the Health and Social Care Committee on 11 May
-
NICE guideline
NICE epilepsies guideline
Covering diagnosing and managing epilepsy in children, young people, and adults
-
News
GPs only refer one in 33 people eligible for weight-management programmes
Eligible young White men are the least likely to be referred for weight-management programmes, researchers have found
-
News
Fourth mRNA vaccine dose shown to give ‘substantial’ immunity boost
A new study from the COV-BOOST trial has found that a fourth dose of a COVID-19 vaccine provides a substantial boost to both antibody and cellular immunity
-
News
Mental Health Awareness Week 2022: loneliness
Taking place from 9 to 15 May, the focus this year is on raising awareness of the impact of loneliness on our mental health and the practical steps we can take to address it
